text_1: Study finds early potential in GSK leukaemia drug
text_2: There are no independent experts quoted. This is not sound journalistic practice, turning the platform over to conflicted sources with no evidence of any critical analysis or independent vetting of claims. The treatment of childhood leukemias has improved considerably in the past several decades. Despite the improvements however, some childhood forms remain difficult. A story about a potential new treatment option is important but it must be presented in a way that does not provide inflated claims and false hope to parents.